Approved IPA / CJC 10

Ipamorelin and CJC-1295 are two of the most widely researched growth hormone secretagogues (GHSs), and when studied together, they provide a synergistic approach to stimulating endogenous GH release.

• Ipamorelin is a highly selective ghrelin receptor (GHS-R1a) agonist. It mimics the action of ghrelin to trigger pulsatile GH release without significantly impacting cortisol or prolactin.
• CJC-1295 is a long-acting analog of Growth Hormone–Releasing Hormone (GHRH). By binding to pituitary receptors and extending GHRH half-life, it sustains GH release and elevates downstream IGF-1.

When combined, CJC-1295 initiates GH release while Ipamorelin amplifies and sharpens the pulse, creating a more physiologic pattern of secretion that mirrors the body’s natural rhythm.

Research Applications and Benefits

The Ipamorelin + CJC-1295 blend has been studied in models exploring:

Muscle Growth and Recovery: By raising GH and IGF-1, the combination supports research into muscle hypertrophy, repair, and recovery from injury or training stress.

Fat Metabolism: GH plays a critical role in lipolysis. Together, CJC-1295 and Ipamorelin enhance the breakdown of stored fat and improve metabolic efficiency in research models.

Sleep and Recovery: Growth hormone is secreted in pulses during deep sleep. This blend’s ability to reinforce natural pulsatility makes it a strong research candidate for restoration and recovery studies.

Bone and Connective Tissue Support: GH/IGF-1 pathways also promote bone density and joint integrity, making this blend relevant in orthopedic and longevity research.

Healthy Aging: With GH secretion declining significantly after age 30, the blend is studied as a potential tool for investigating age-related decline, vitality, and metabolic health.

As with all peptides made available for research purposes only, our Ipamorelin + CJC-1295 blend is not approved for human consumption or therapeutic use. 

• Stability – Supplied in lyophilized form and should be stored in a cool, dry environment until reconstitution.
• Regulatory Status – Both peptides remain investigational and are not FDA-approved outside of clinical research. 
• Research Integrity – This blend should be studied only in controlled laboratory environments under strict compliance with ethical and regulatory standards.

The Ipamorelin + CJC-1295 blend represents one of the most effective combinations for studying growth hormone biology, offering a dual mechanism that mimics the body’s natural GH rhythms.

With applications in muscle recovery, fat metabolism, tissue repair, and healthy aging, this blend continues to be a cornerstone tool for advancing research on the GH/IGF-1 axis and regenerative health.